S
Stedical Scientific
Disruptive healthcare innovations unlocking hidden solutions for unmet medical needs
About Stedical Scientific
Stedical Scientific is dedicated to revolutionizing the healthcare sector by introducing disruptive innovations that address unmet medical needs. The company focuses on surfacing hidden solutions and matching them with global healthcare demands. With a strong leadership team, including Executive Chairman Leo Spiegel and Chief Medical Officer Aubrey Woodroof, Stedical leverages extensive expertise in medical device development. The company has a history of creating and patenting various medical devices, such as tissue heart valves and wound dressings. Stedical operates in the medical device market, serving healthcare providers and patients worldwide. Its business model revolves around developing patented medical technologies and bringing them to market, generating revenue through product sales and licensing agreements. The company aims to improve global access to advanced healthcare technologies, enhancing patient outcomes and quality of life.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Carlsbad, United States
- Employees
- 12
- Open positions
- None listed
- Dealroom signal
- 78.7/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery, wound care, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Feb 2025 | $28M | $110M | SHC Shanghai Biomedical Fund · Longpan Investment | ↗ |
Growth signals
Latest recorded traffic for Stedical Scientific is 1.4K monthly website visits, up 174.5% over the last three months. Stedical Scientific's team grew 33.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
SHC Shanghai Biomedical Fund- LILongpan Investment
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Stedical Scientific on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Stedical Scientific’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







